Related Experiment Video
Updated: May 18, 2026
09:08
From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Engineering of plant type III polyketide synthases
Toshiyuki Wakimoto1, Hiroyuki Morita, Ikuro Abe
1Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Methods in Enzymology
|September 25, 2012
Summary
Researchers engineered plant type III polyketide synthases (PKSs) to create novel polyketide scaffolds. These modified enzymes show expanded catalytic abilities and potential for producing new compounds with valuable biological activities.
Area of Science:
- Biochemistry
- Enzyme Engineering
- Synthetic Biology
Background:
- Type III polyketide synthases (PKSs) are enzymes that produce diverse polyketide scaffolds.
- These enzymes share a conserved structure but can be modified to expand their catalytic functions.
- Their promiscuous substrate specificity makes them ideal for generating novel compounds.
Purpose of the Study:
- To summarize recent advances in engineering plant type III PKS enzymes.
- To explore the production of unnatural polyketide scaffolds with enhanced biological activities.
- To utilize structure-based enzyme engineering and precursor-directed biosynthesis.
Main Methods:
- Structure-based enzyme engineering of plant type III PKSs.
- Rational design of substrate analogs.
- Precursor-directed biosynthesis strategies.
- Characterization of engineered enzyme activity and product profiles.
Main Results:
- Demonstrated successful engineering of plant type III PKSs to alter substrate specificity and catalytic output.
- Generated novel polyketide scaffolds with potential for new biological activities.
- Showcased the enzyme's versatility as a platform for producing unnatural compounds.
Conclusions:
- Engineering plant type III PKSs is a viable strategy for expanding polyketide diversity.
- Modified PKSs can produce novel scaffolds with promising therapeutic or industrial applications.
- Combining enzyme engineering with biosynthesis offers a powerful approach for creating new molecules.
Related Concept Videos
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:24Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
02:50Transgenic Plants
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
01:25Cell Signaling in Plants
Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...